Do you have known or suspected lung and/or head and neck cancer? Are you scheduled for a tumor biopsy? If so, you may be able to participate in a research registry aimed at learning more about lung and head/neck cancer.
Are you receiving initial treatment for non-small cell lung cancer or invasive squamous cell carcinoma of the head and neck and want to participate in research that aims to improve treatment and care of future patients with the same diagnosis? If so, you may be able to participate in a study for an investigational blood test to predict whether your cancer will come back.
The purpose of this study is to investigate the effects of using durvalumab plus platinum doublet chemotherapy (carboplatin/abraxane or carboplatin/pemetrexed) with or without abequolixron (RGX-104) in patients with non-small cell lung cancer (NSCLC) before surgery.
In this study, we want to learn more about the safety and effectiveness of using a personalized vaccine with a drug called pembrolizumab for the treatment of non‐small cell lung cancer (NSCLC) and squamous cell cancer of the head and neck (SCCHN).
We are doing a study to help us adapt a physical activity program for adults with intellectual disabilities. We are looking for adults with intellectual disabilities, parents/caregivers, support staff, and exercise professionals to complete a survey and take part in interviews or focus groups to provide feedback on a physical activity program. The program includes weekly group fitness meetings, one-to-one coaching meetings, and an app to support setting, monitoring, and achieving exercise goals.
The purpose of this study is to evaluate MEDI5752 alone or in combination with other drugs in adult subjects with advanced solid tumors.
This is a research study for people diagnosed with High Risk Myelofibrosis. The purpose of this study is to see if the study drug BMS-986158 works better alone or in combination with ruxolitinib or fedratinib.
Have you been diagnosed with small cell lung cancer? Is your current treatment no longer working in controlling your cancer? If so, you may be able to take part in a research study looking at giving trilaciclib to help minimize the side effects of lurbinectedin.
Have you been diagnosed with Leukemia and looking for another option? Do you have Chronic Myelogenous Leukemia? In this study, we want to learn more about how effective the study drug (asciminib) works for patients with CML-CP who have had one prior therapy.
Does your child have recurrent wheezing? They may be able to take part in the EAGLE study to help us learn if a new medication may help.